Quantum Biopharma Ltd. (QNTM) Times Interest Earned (2019 - 2026)

Quantum Biopharma (QNTM) has 8 years of Times Interest Earned data on file, last reported at -$129.79 in Q1 2026.

• Quarterly Times Interest Earned rose 15.31% year-over-year to -$129.79 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$93.68 (up 69.48% YoY) and the FY2025 annual result came in at -$96.81, up 80.19% from the prior year.
• Times Interest Earned eased to -$129.79 in Q1 2026 per QNTM's latest filing, from $32.67 in the prior quarter.
• The five-year high for Times Interest Earned was $344.87 in Q1 2022, with the low at -$14760.1 in Q1 2023.
• Average Times Interest Earned over 5 years is -$1533.8, with a median of -$153.26 recorded in 2025.
• Year-over-year, Times Interest Earned plunged 4379.89% in 2023 and soared 102.93% in 2025.
• Quantum Biopharma's Times Interest Earned stood at $344.87 in 2022, then sank by 4379.89% to -$14760.1 in 2023, then surged by 92.44% to -$1115.4 in 2024, then soared by 102.93% to $32.67 in 2025, then tumbled by 497.23% to -$129.79 in 2026.
• Business Quant data shows QNTM's Times Interest Earned at -$129.79 in Q1 2026, $32.67 in Q4 2025, and -$51.09 in Q3 2025.